Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by InvrsContrarianon Apr 07, 2021 2:35pm
120 Views
Post# 32950652

RE:RE:RE:Full clarus update

RE:RE:RE:Full clarus updateStill in it, got a foot in, barely. Works??? Clarus got burned and they retaliated look in their quote. Near the middle end of his thoughts. "Potential DTC customers will need to be able to do their own research beyond the general specificity/sensitivity data offered by SZLS to date; ideally this will be similar in depth of content to journal articles recently published on the competing Grail and Thrive pan-cancer liquid biopsy products it needs to be sufficiently detailed to allow a potential patient to take the materials to their family doctor or oncologist and ask for their professional opinion on whether Aristotle works, Atkinson wrote." Again he says works? Thats the billion dollar question.
Oilersgoforcup wrote:
Thinking out loud>>>


Mercer wanted the test for $495

At that level SZLS is giving up $1000 per test

Tripp's new route...charge $1500 cause everyone is in panic mode right now due to covid...$1500 to see if you got cancer is peanuts....just imagine...you got tested positive for cancer and you can now prepare your diet, job, retirement and future plans much more in advance.

SZLS makes much more $$ this way.

If ARISTOTLE is the CREAM....the COFFEE will always be there and the COFFEE will look for the CREAM ....get it !!!!


<< Previous
Bullboard Posts
Next >>